TransMolecular's Series B Round

TransMolecular raised a round of funding on September 12, 2000.

Transmolecular is a biotechnology company targeting disorders of the central nervous system. The company is committed to discovering, developing, and commercializing targeted therapies for glioma, met…

Articles about TransMolecular's Series B Round: